Article
Mitochondrial Pyruvate Carrier Inhibition Attenuates Hepatic Stellate Cell Activation and…
medRxiv · 2023 · Habibi, M.; Ferguson, D.; Eichler, S. J.; Chan, M. M.; LaPoint, A.; Shew, T. M.; He, M.; Lutkewitte, A. J.; Schilling, J. D.; Cho, K. Y.; Patti, G.; Finck, B. N.
Key facts
| Title | Mitochondrial Pyruvate Carrier Inhibition Attenuates Hepatic Stellate Cell Activation and Liver Injury in a Mouse Model of Metabolic Dysfunction-associated Steatotic Liver Disease |
|---|---|
| First author | Habibi, M.; Ferguson, D.; Eichler, S. J.; Chan, M. M.; LaPoint, A.; Shew, T. M.; He, M.; Lutkewitte, A. J.; Schilling, J. D.; Cho, K. Y.; Patti, G.; Finck, B. N. |
| Journal | medRxiv |
| Published | Aug 25, 2023 |
| DOI | 10.1101/2023.02.13.528384 |
| Devices mentioned | BK110039, DEN000008, K022086, K071580, K103302, K875071, K942648, K981650 |
| Product codes mentioned | CIT, JCI, KIT, LXG, MVU, NDS, NJT, OOI, JIL, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1